| PDF (1MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-204405
- DOI to cite this document:
- 10.5283/epub.20440
Abstract
To reduce the opportunities for human immunodeficiency virus type 1 (HIV-1) to evade vaccine induced immunity, the development of subunit vaccines must focus on the characterization of immunogenic epitopes, which are major targets for the immune system. The most dominant site for elicitation of neutralising immune response is located on the external envelope glycoprotein gp120 within the third ...
Owner only: item control page